Kwivik Therapeutics Inc

Kwivik Therapeutics is a pre-IPO medtech leader with a robust pipeline of novel products for respiratory, emergency medical, asthma, cluster headache/migraine, wound care and skin care markets. Our patent protected methodologies combine innovative biotech, engineering, IoT and IA technologies to create category killers in multiple mega markets in the therapeutics, emergency medical, and pandemic preparedness sectors globally.

Company’s Keywords:

emergency oxygen for lay person use, novel oxygenated nebulizer for home use by asthma sufferers, novel oxygenated aerosolizer for asthma sufferers, novel solutions for cluster headache, migraine, skin care & wound care markets, ppe, pandemic readiness & emergency medical, iot & ai